Clinical Trials Directory

Trials / Terminated

TerminatedNCT03694821

Knee Injection RCT

Efficacy and Cost-effectiveness of Intra-Articular Ketorolac Injection for Knee Osteoarthritis: A Randomized, Controlled, Double-Blinded Study

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
18 (actual)
Sponsor
UConn Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: Ketorolac injection is a cost-effective adjunct in the nonoperative treatment of knee osteoarthritis (OA) compared to steroids and viscosupplementation. Aims/objectives: The objective of this randomized, controlled, double-blinded, prospective study is to assess the efficacy and cost-effectiveness of knee injection with ketorolac in the nonsurgical management of symptomatic OA compared to injections with corticosteroids and viscosupplements.

Detailed description

The purpose of this research study is to examine the effectiveness of intra-articular (inside the joint) ketorolac injection compared to injection with either corticosteroid or hyaluronic acid for the treatment of painful knee osteoarthritis. Patients will be randomly assigned to receive either ketorolac (a nonsteroidal anti-inflammatory drug, methylprednisolone (a steroid), hyaluronic acid (a substance that is naturally present in the human body).

Conditions

Interventions

TypeNameDescription
DRUGKetorolac Tromethamine InjectionOne knee injection of 2cc of ketorolac tromethamine (15mg/cc) in 5cc of 0.5% ropivacaine hydrochloride without epinephrine
DRUGMethylprednisolone Acetate InjectionOne knee injection of 2 cc of methylprednisolone acetate (40mg/cc) in 5cc of 0.5% ropivacaine hydrochloride without epinephrine
DRUGHylan G-F 20One knee injection of Hylan G-F 20 (Synvisc-One)

Timeline

Start date
2018-07-05
Primary completion
2019-07-16
Completion
2019-07-16
First posted
2018-10-03
Last updated
2020-02-18
Results posted
2020-02-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03694821. Inclusion in this directory is not an endorsement.